Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Big Pharma CEOs get candid about pricing and M&A
Pharma Voice
Mon, 07/31/23 - 10:03 am
Tags:
Big Pharma, Pharma CEOs, drug pricing, M&A, JNJ, Merck, GSK
Alkermes, nearing oncology split, posts big Q2 sales gain after winning J&J arbitration case
Fierce Pharma
Wed, 07/26/23 - 06:37 pm
Tags:
JNJ, Alkermes, oncology, earnings
J&J, GSK's ViiV tout switching study showing patients prefer their long-acting HIV med Cabenuva over Gilead rival
Fierce Pharma
Tue, 07/25/23 - 09:20 pm
Tags:
JNJ, GSK, ViiV, Gilead Sciences, HIV, Cabenuva, Biktarvy
J&J outlines exchange offer for Kenvue shares
Medical Marketing and Media
Mon, 07/24/23 - 09:39 pm
Tags:
JNJ, Kenvue, shareholders
Pfizer, Gilead, GSK to Capture Growing Infectious Diseases Market as J&J Pulls Back
BioSpace
Mon, 07/24/23 - 10:26 am
Tags:
infectious diseases, Pfizer, Gilead Sciences, GSK, JNJ
J&J’s 2Q23 Results Show It’s a Force to Be Reckoned with in Medtech
Medical Devices and Diagnostics Industry
Sun, 07/23/23 - 12:40 pm
Tags:
JNJ, Medtech, earnings
J&J flags potential interference between heart pump and TAVR stents in recall
Medtech Dive
Fri, 07/21/23 - 11:56 am
Tags:
JNJ, Abiomed, TAVR, Impella, device recalls, Medtech
J&J Exceeds Q2 Expectations, Oncology and Immunology Top Pharma Drivers
BioSpace
Thu, 07/20/23 - 09:51 pm
Tags:
JNJ, earnings
Janssen’s newly-merged infectious disease and vaccine unit sees significant pipeline cuts
Fierce Biotech
Thu, 07/20/23 - 10:18 am
Tags:
JNJ, Janssen, infectious disease, vaccines, hepatitis, HIV
Abiomed’s Impella System Hit with Another Recall
Medical Devices and Diagnostics Industry
Wed, 07/19/23 - 05:47 pm
Tags:
JNJ, Abiomed, Impella, TAVR, device recalls, Medtech
J&J ordered to pay mesothelioma patient $18.8M in talc case, pledges to appeal
Fierce Pharma
Wed, 07/19/23 - 11:46 am
Tags:
JNJ, legal, mesothelioma
House Judiciary Committee Probes Big Pharma’s Potential Role in COVID-19 Censorship
BioSpace
Wed, 07/19/23 - 10:23 am
Tags:
Pfizer, JNJ, Merck, Big Pharma, COVID-19, US Congress
Johnson & Johnson becomes 4th drugmaker to file suit against IRA's drug price negotiations
Fierce Pharma
Tue, 07/18/23 - 10:07 pm
Tags:
JNJ, drug pricing, Inflation Reduction Act
J&J touts Rybrevant win in newly diagnosed lung cancer, with key Tagrisso head-to-head readout up next
Fierce Pharma
Mon, 07/17/23 - 07:04 pm
Tags:
JNJ, Rybrevant, non-small cell lung cancer, Takeda, Tagrisso
See which pharma brands are the strongest and fastest-growing in 2023
Medical Marketing and Media
Wed, 07/12/23 - 11:12 pm
Tags:
JNJ, Pfizer, CSL, branding
J&J's Ethicon Faces Mega Electrode Recall
Medical Devices and Diagnostics Industry
Wed, 07/12/23 - 09:26 am
Tags:
Medtech, JNJ, Ethicon, electrodes, device recalls, electrosurger
Janssen emerges as 11th-hour financier for Nanobiotix in $2B+ deal
Medical Marketing and Media
Tue, 07/11/23 - 11:27 pm
Tags:
JNJ, Janssen, Nanobiotix, NBTXR3, soft tissue sarcoma, Hensify
J&J Extends Lifeline to Nanobiotix in Potential $1.8B Licensing Deal
BioSpace
Mon, 07/10/23 - 09:36 pm
Tags:
JNJ, Nanobiotix, NBTXR3, radiotherapy, head and neck cancer
Janssen’s trial of plaque psoriasis therapy meets endpoints
Clinical Trials Arena
Wed, 07/5/23 - 10:18 am
Tags:
Janssen, JNJ, clinical trials, JNJ-2113, plaque psoriasis
Former J&J sales rep indicted on charges of defrauding Boston hospital
Medtech Dive
Thu, 06/29/23 - 11:37 am
Tags:
Medtech, fraud, JNJ, DePuy Synthes, legal, Boston

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.